TrialThe Journal of infectious diseases2022

Immunogenicity of Reduced-Dose Monovalent Type 2 Oral Poliovirus Vaccine in Mocuba, Mozambique.

Nilsa de Deus et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.